CME Group said it held its May 9, 2024 annual shareholder meeting. Of the 360,025,217 shares issued and outstanding as of the record date, March 11, 2024, 314,467,507 shares, or 87.34%, were present.

1. 01

   CME Group said it held its May 9, 2024 annual shareholder meeting. Of the 360,025,217 shares issued and outstanding as of the record date, March 11, 2024, 314,467,507 shares, or 87.34%, were present.

2. 02

   CME Group said shareholders voting together as a single class elected seventeen Equity Directors to serve until 2025. For Terrence A. Duffy, there were 264,576,518 votes for and 23,927,907 against.

3. 03

   The company said the ratification of Ernst & Young LLP as its independent public accounting firm drew 289,766,319 votes for and 24,482,330 against. The advisory vote on named executive officer compensation was approved with 253,068,323 votes for and 37,272,265 against.

4. 04

   CME Group said no quorum was reached in the elections for Class B-1, B-2 and B-3 directors. As a result, those directors are holdovers under Delaware law and the company's bylaws and will continue to serve until their successors are elected at the 2025 annual meeting.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.